Mirvie Becomes First RNA-Based Pregnancy Health-Focused Company to Receive Clinical Laboratory Improvement Amendments (CLIA) Certification
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Mirvie, a pioneer in predicting unexpected pregnancy complications, today announced its South San Francisco-based laboratory has been certified by the Centers for Medicare and Medicaid Services (CMS) under the Clinical Laboratory Improvement Amendments (CLIA) to perform high-complexity clinical testing. “We are extremely proud to have received CLIA certification, which marks a crucial milestone in our journey towards commercializing the Mirvie RNA p ...
